Literature DB >> 10450807

Restricted occurrence of Lewy bodies in the dorsal vagal nucleus in a patient with late-onset parkinsonism.

K Wakabayashi1, Y Toyoshima, K Awamori, T Anezaki, M Yoshimoto, S Tsuji, H Takahashi.   

Abstract

Lewy body (LB) is consistently found in the substantia nigra in Parkinson's disease. We report a 68-year-old woman with late-onset, dopa-responsive parkinsonism. Her parents were first cousins, but no other affected individuals were present in the family. Autopsy revealed moderate loss of pigmented neurons with gliosis, but neither LBs nor neurofibrillary tangles in the substantia nigra. The locus ceruleus showed neuronal loss with scarce LBs. The most striking change was found in the dorsal vagal nucleus, where marked neuronal loss and fibrillary gliosis with many LBs were evident. Despite the use of ubiquitin and alpha-synuclein immunohistochemistry, no further LBs were identified in other brain regions. These findings suggest that this case was an unusual, anatomically restricted manifestation of LB disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10450807     DOI: 10.1016/s0022-510x(99)00101-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

Review 1.  Innervation of the gastrointestinal tract: patterns of aging.

Authors:  Robert J Phillips; Terry L Powley
Journal:  Auton Neurosci       Date:  2007-05-29       Impact factor: 3.145

Review 2.  Dysautonomia in Parkinson disease.

Authors:  David S Goldstein
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

3.  Oral administration of rotenone using a gavage and image analysis of alpha-synuclein inclusions in the enteric nervous system.

Authors:  Francisco J Pan-Montojo; Richard H W Funk
Journal:  J Vis Exp       Date:  2010-10-26       Impact factor: 1.355

4.  Prokineticin-2 promotes chemotaxis and alternative A2 reactivity of astrocytes.

Authors:  Matthew Neal; Jie Luo; Dilshan S Harischandra; Richard Gordon; Souvarish Sarkar; Huajun Jin; Vellareddy Anantharam; Laurent Désaubry; Anumantha Kanthasamy; Arthi Kanthasamy
Journal:  Glia       Date:  2018-09-12       Impact factor: 7.452

Review 5.  Inflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link?

Authors:  Carla M Lema Tomé; Trevor Tyson; Nolwen L Rey; Stefan Grathwohl; Markus Britschgi; Patrik Brundin
Journal:  Mol Neurobiol       Date:  2012-04-29       Impact factor: 5.590

6.  Mitochondrial dysfunction in Parkinson's disease.

Authors:  P C Keane; M Kurzawa; P G Blain; C M Morris
Journal:  Parkinsons Dis       Date:  2011-03-15

7.  Contribution of Alanine-76 and Serine Phosphorylation in α-Synuclein Membrane Association and Aggregation in Yeasts.

Authors:  Michael Fiske; Stephanie Valtierra; Keith Solvang; Michael Zorniak; Michael White; Sara Herrera; Alina Konnikova; Rebecca Brezinsky; Shubhik Debburman
Journal:  Parkinsons Dis       Date:  2011-07-03

Review 8.  What is the Evidence That Parkinson's Disease is a Prion Disorder, Which Originates in the Gut?

Authors:  Małgorzata Kujawska; Jadwiga Jodynis-Liebert
Journal:  Int J Mol Sci       Date:  2018-11-12       Impact factor: 5.923

9.  6-hydroxydopamine and ovariectomy has no effect on heart rate variability parameters of females.

Authors:  Tomás de la Rosa; Viviam Sanabria Calvo; Valeria Cassia Gonçalves; Débora Amado Scerni; Fúlvio Alexandre Scorza
Journal:  Clinics (Sao Paulo)       Date:  2021-10-11       Impact factor: 2.365

Review 10.  Neuroinflammation in neurodegeneration via microbial infections.

Authors:  Van Thi Ai Tran; Luke P Lee; Hansang Cho
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.